Background Adjuvant chemotherapy with anthracyclines improves disease-free and overall
survival compared with non–anthracycline-based adjuvant chemotherapy regimens in the …

Context Premenopausal patients with breast cancer are at high risk of premature ovarian
failure induced by systemic treatments, but no standard strategies for preventing this adverse …

Background Increasing the dose intensity of cytotoxic therapy by shortening the intervals
between cycles, or by giving individual drugs sequentially at full dose rather than in lower-dose …

In the last decade, the treatment of non-small cell lung cancer (NSCLC) has been revolutionized
by the introduction of immune checkpoint inhibitors (ICI) directed against programmed …

Background The role of temporary ovarian suppression with luteinizing hormone-releasing
hormone agonists (LHRHa) in the prevention of chemotherapy-induced premature ovarian …

Background The role of temporary ovarian suppression with gonadotropin-releasing hormone
analogues (GnRHa) in the prevention of chemotherapy-induced premature ovarian failure …

Importance Whether the administration of luteinizing hormone–releasing hormone analogues
(LHRHa) during chemotherapy is a reliable strategy to preserve ovarian function is …

Background: To determine whether a dose-dense regimen improves outcome in early
breast cancer patients, we compared outcomes with the same fluorouracil, epirubicin, and …

Background Targeted therapy and immunotherapy have shown intracranial activity in
melanoma with CNS metastases, but there remains an unmet need, particularly for patients with …

Background A systematic review and meta-analysis was performed to estimate mortality in
adult patients with solid or hematological malignancies and SARS-CoV-2 infection. Methods …